A recent review of the drug statins, argues that the benefits of the cholesterol-reducing treatment have been underestimated.
A number of major health organisations back the findings published in the Lancet, saying the drug lowers heart attack and stroke risks, while the side-effects occur in relatively few people.
Our UK Correspondent Natalie Powell reports
IN: Around six million
OUT: SOC
DUR: 36 seconds
AIR: http://www.fsnradionews.com/feeds/0909statins-np-air.mp3
ARN: http://www.fsnradionews.com/feeds/0909statins-np-arn.mp3
FM4: http://www.fsnradionews.com/feeds/0909statins-np-fm4.mp3
GENERIC: http://www.fsnradionews.com/feeds/0909statins-np-generic.mp3
ICRT: http://www.fsnradionews.com/feeds/0909statins-np-icrt.mp3
NIGERIA: http://www.fsnradionews.com/feeds/0909statins-np-von.mp3
RNZ: http://www.fsnradionews.com/feeds/0909statins-np-rnz.mp3
SRN: http://www.fsnradionews.com/feeds/0909statins-np-srn.mp3
VATICAN: http://www.fsnradionews.com/feeds/0909statins-np-vatican.mp3
ZIZ: http://www.fsnradionews.com/feeds/0909statins-np-ziz.mp3
938: http://www.fsnradionews.com/feeds/0909statins-np-938.mp3